sécurité sociale – Baisse des tarifs de biologie médicale

This written question concerns the tariffs for medical biology analyses within the social security system. It seeks clarification on potential reductions and their impact on healthcare costs and access. The question addresses the implications for patients, healthcare providers, and the overall sustainability of social security funding in France.